Literature DB >> 2615196

Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group.

M M Schwartz1, J Bernstein, G S Hill, K Holley, E A Phillips.   

Abstract

We tested the value of the activity (AI) and chronicity (CI) indices devised by Austin et al as predictors of outcome in lupus patients with diffuse proliferative glomerulonephritis (DPGN). Four renal pathologists independently scored the AI and CI on 84 renal biopsy specimens from patients with lupus DPGN followed for 109 +/- 74 weeks (mean +/- SD), and the mean score was compared to the development of renal failure and to adverse outcome (combined data for renal failure, death and predefined clinical stop points). Receiver operator characteristic curves were derived from a series of 2 x 2 tables in which one variable was renal failure or adverse outcome and the other variable was AI or CI dichotomized by a cut-off point. Over the entire range (0 to 10) of the CI there was no value that separated patients who developed renal failure from those who did not. The ROC curve analysis indicated that the sensitivity and specificity of the CI were too low to allow it to function as a good test. Once patients entering renal failure were identified, the mean CI approached but did not reach a significant difference when compared to the mean CI of those who did not go into renal failure (4.38 +/- 0.42, mean +/- SE vs. 3.19 +/- 0.23, P = 0.0620). The CI did not predict the adverse clinical outcomes. There was no cut-off value of the CI which separated patients who had an adverse outcome from those who did not, and this result was confirmed by ROC analysis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2615196     DOI: 10.1038/ki.1989.276

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  The significance of arterial hypertension at the onset of clinical lupus nephritis.

Authors:  I P Naiker; V Chrystal; I G Randeree; Y K Seedat
Journal:  Postgrad Med J       Date:  1997-04       Impact factor: 2.401

2.  Value of a complete or partial remission in severe lupus nephritis.

Authors:  Yiann E Chen; Stephen M Korbet; Robert S Katz; Melvin M Schwartz; Edmund J Lewis
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-14       Impact factor: 8.237

3.  Lupus nephritis in childhood: a review of 53 patients followed at a single center.

Authors:  Radovan Bogdanović; Vesna Nikolić; Srdjan Pasić; Jovan Dimitrijević; Jasmina Lipkovska-Marković; Jelena Erić-Marinković; Milos Ognjanović; Aleksandra Minić; Natasa Stajić
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

Review 4.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

5.  Clinicopathological study of the WHO classification in childhood lupus nephritis.

Authors:  Michael Zappitelli; Ciaran Duffy; Chantal Bernard; Rosie Scuccimarri; Karen Watanabe Duffy; Rhoda Kagan; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2004-03-12       Impact factor: 3.714

6.  Long-term renal outcome and complications in South Africans with proliferative lupus nephritis.

Authors:  Olugbenga E Ayodele; Ikechi G Okpechi; Charles R Swanepoel
Journal:  Int Urol Nephrol       Date:  2013-01-10       Impact factor: 2.370

7.  The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy.

Authors:  S K Annavarajula; K V D Murty; A Prayaga; U Das; M Desai; C A Narain
Journal:  Indian J Nephrol       Date:  2011-07

8.  Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.

Authors:  Lindsey E Romick-Rosendale; Hermine I Brunner; Michael R Bennett; Rina Mina; Shannen Nelson; Michelle Petri; Adnan Kiani; Prasad Devarajan; Michael A Kennedy
Journal:  Arthritis Res Ther       Date:  2011-12-07       Impact factor: 5.156

9.  The Impact of Baseline Serum Creatinine on Complete Remission Rate and Long-Term Outcome in Patients with Severe Lupus Nephritis.

Authors:  Stephen M Korbet; William L Whittier; Edmund J Lewis
Journal:  Nephron Extra       Date:  2016-08-18

10.  A clinico-pathological study of lupus nephritis based on the International Society of Nephrology-Renal Pathology Society 2003 classification system.

Authors:  Suchitha Satish; Pallavi Deka; Manjunath Sanjeev Shetty
Journal:  J Lab Physicians       Date:  2017 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.